Fixed ratio combination of basal insulin and GLP-1 receptor agonist

Iglarlixi2 sc 15-30ug other

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

IGLARLIXI2_SC_15-30UG_OTHER

Mechanism: IDegLira; iGlarLixi; IcoSema
Trials: 0
Participants in these arms: 0

All doses pooled: Insulin glargine with lixisenatide injection
IGlarLixi 2:1 pen subcutaneous once daily titrated
Iglarlixi2 sc 5-5ug other
Iglarlixi2 sc 10-10ug other

Iglarlixi2 sc 15-30ug other

Related

Trials